HIV and aging: new study to uncover hidden frailty risks

NCT ID NCT07453303

Not yet recruiting Knowledge-focused Sponsor: Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will compare 80 adults aged 40 and older—half living with HIV and half healthy—to see if those with HIV experience frailty, muscle loss, and cognitive decline earlier. Researchers will assess physical function, nutrition, and thinking skills. The goal is to understand how HIV may speed up age-related problems, which could guide future prevention efforts.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could reveal how HIV affects aging, pointing to ways to prevent frailty and muscle loss in people living with HIV.

What could go wrong

This is an observational study, not a treatment trial. It will not test any new drug or therapy, so it cannot directly improve health.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FRAILTY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Frailty HIV infectious disease Sarcopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FRAILTY SARCOPENIA